cancer treatment

cancer treatment

Amivantamab Seeks FDA Nod for Non-Small Cell Lung Cancer

Rebecca AraujoNon-Small Cell Lung Cancer | September 21, 2023

Janssen Pharmaceuticals has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) ...

Lurbinectedin Successful Second-Line Treatment for Small-Cell Lung Cancer Patients After First-Line Failure

Kaitlyn D’OnofrioSmall Cell Lung Cancer | September 20, 2023

Lurbinectedin may be a viable option as a second-line treatment for small-cell lung cancer (SCLC) patients whose ...

Experimental Drug Shows Promise in Treating Lung and Kidney Cancer

DocWire News EditorsNon-Small Cell Lung Cancer | September 20, 2023

A new study has found that patients with non-small cell lung cancer (NSCLC) and kidney cancer may benefit from ...

First-Line Lorlatinib Improves Survival and Metastasis in Advanced ALK-Positive Lung Cancer

Rebecca AraujoNon-Small Cell Lung Cancer | November 19, 2020

Early treatment with the anaplastic lymphoma kinase (ALK)-inhibitor lorlatinib reduced cancer progression and death in ...

Latest News

Testing Category 1

August 29, 2025

Guided by Data: Navigating Biopsies, Biomarkers, and Treatment Strategies in NSCLC

August 13, 2025

From Screening to Strategy: Navigating the First Steps in Lung Cancer Care

August 12, 2025

FDA Grants Accelerated Approval to Zongertinib for NSCLC With HER2 TKD-Activating Mutations

August 11, 2025

Surgery for NSCLC: Multidisciplinary Panel Discusses Operative Considerations

August 11, 2025

Managing Side Effects in Patients With NSCLC: Experts Share Strategies

August 11, 2025

Physician's Weekly

Family Practice

FDA Approves Gardenia-Based Blue Dye for Use in Foods and Drinks

Family Practice

Most Major Ice Cream Brands Will Remove Synthetic Dyes by 2028

Dermatology

Atopic Dermatitis May Be Linked to Increased Risk for CKD